e-learning
resources
Stockholm 2007
Monday 17.09.2007
New perspectives and old problems in diagnosing tuberculosis infection and disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Does anti TNF-α treatment increase tuberculosis risk?
B. Musellim, F. Zuhur, G. Ongen, I. Ozdemir, S. Erturan, G. Hatemi, V. Hamuryudan (Istanbul, Turkey)
Source:
Annual Congress 2007 - New perspectives and old problems in diagnosing tuberculosis infection and disease
Session:
New perspectives and old problems in diagnosing tuberculosis infection and disease
Session type:
Oral Presentation
Number:
1773
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
B. Musellim, F. Zuhur, G. Ongen, I. Ozdemir, S. Erturan, G. Hatemi, V. Hamuryudan (Istanbul, Turkey). Does anti TNF-α treatment increase tuberculosis risk?. Eur Respir J 2007; 30: Suppl. 51, 1773
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Who is at risk for active tuberculosis?
Source: Annual Congress 2003 - Latent tuberculosis infection - preventive approaches
Year: 2003
Contact screening in tuberculosis. Can we identify those with higher risk?
Source: Annual Congress 2012 - Tuberculosis: epidemiological and public health features
Year: 2012
Prevalence and treatment outcome of drug resistant pulmonary tuberculosis in HIV negative cases – experience from a tuberculosis treatment center in India
Source: Annual Congress 2009 - Multi/extensively-drug resistant tuberculosis
Year: 2009
Who are at risk for tuberculosis recurrence?
Source: Annual Congress 2011 - Challenges in tuberculosis control
Year: 2011
Impact of anti tuberculosis therapy in plasma zinc status in childhood tuberculosis
Source: Eur Respir J 2005; 26: Suppl. 49, 455s
Year: 2005
Contact screening in tuberculosis: can we identify those with higher risk?
Source: Eur Respir J 2013; 41: 758-760
Year: 2013
Does the clinical symptoms of drug resistant pulmonary tuberculosis (PTB) act as a predictor in HIV non-infected/infected patient? An Indian scenario
Source: Eur Respir J 2006; 28: Suppl. 50, 858s
Year: 2006
Is it smoking a risk factor in tuberculosis?
Source: Annual Congress 2010 - Tuberculosis: metabolic insights
Year: 2010
The treatment of tuberculosis and application of HAART (highly active anti retroviral treatment) in HIV positive patients
Source: Annual Congress 2005 - Challenges in the management of pulmonary tuberculosis: a continuous clinical problem
Year: 2005
Identification of high risk factors for development of active tuberculosis in children with latent tuberculosis infections
Source: International Congress 2017 – Clinical challenges in chronic lung diseases
Year: 2017
The risk of ineffective MDR/XDR TB treatment, based on bedaquilin: factors and their influence
Source: Virtual Congress 2020 – Multidrug-resistant tuberculosis
Year: 2020
Intensive tobacco smoking as a factor of the decrease of treatment effectiveness in patients with pulmonary tuberculosis (TB)
Source: Eur Respir J 2005; 26: Suppl. 49, 157s
Year: 2005
How does tobacco-smoking contribute to the tuberculosis burden?
Source: Annual Congress 2007 - Tuberculosis control and HIV in Europe: good or bad news?
Year: 2007
Impact of smoking on outcome of treatment of tuberculosis in patients taking intermittent treatment of tuberculosis under India‘s revised tuberculosis control program
Source: Annual Congress 2008 - Health effects of passive smoking and of a smoking ban
Year: 2008
The causes of ineffectiveness of treatment of tuberculosis in children
Source: Eur Respir J 2005; 26: Suppl. 49, 649s
Year: 2005
Fenofibrate is associated with higher risk of mortality in patients with tuberculosis infection
Source: International Congress 2019 – Tuberculosis: from diagnosis to complications
Year: 2019
Attempt to estimate risk factors for drug resistance (DR) in tuberculosis
Source: Eur Respir J 2005; 26: Suppl. 49, 653s
Year: 2005
Smoking is a risk factor for TB infection, but is it an additional mortality risk?
Source: Annual Congress 2011 - Management of tuberculosis
Year: 2011
A combinatorial dual-immunoassay predicts reactivation risk for patients with previously incomplete treatment for latent tuberculosis infection
Source: International Congress 2016 – Active and latent tuberculosis: biomarkers
Year: 2016
Cost-effectiveness of interferon-γ release assay testing for the treatment of latent tuberculosis
Source: Eur Respir J 2007; 30: 321-332
Year: 2007
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept